Author: Zhang Chunjiao
Recently, QYResearch published a report on global enzymatic debridement market. Enzymatic debridement uses chemical enzymes to assist in wound healing. Enzymes that help slough off the dead tissue are often available as part of a topic ointment; however, the ointment must be carefully applied to only the currently dead tissue – if the enzymes come in contact with healthy tissue, they could cause issues.
In the last several years, global market of enzymatic debridement developed rapidly, with an average growth rate of 7.3%. In 2016, global revenue of enzymatic debridement is nearly 182 M USD; the actual production is about 2380 K units.
The classification of enzymatic debridement includes collagenase product, papain product and other product, and the proportion of collagenase product in 2016 is about 75%. Enzymatic debridement is widely used in hospitals, clinics and other field. The most proportion of enzymatic debridement is hospitals, and the consumption proportion is about 49% in 2016.
North America region is the largest supplier of enzymatic debridement, with a production market share nearly 44% in 2016. Europe is the second largest supplier of Enzymatic Debridement, enjoying production market share nearly 29% in 2016.
North America is the largest consumption place, with a consumption market share nearly 61% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 15%.
Market competition is intense. Smith & Nephew is the leaders of the industry, and it holds key technologies and patents, with high-end customers; has been formed in the monopoly position in the industry. www.qyresearchglobal.com
This article was first released by QYResearch analyst, if reproduced, please indicate the source.
Media Contact: firstname.lastname@example.org
Sales & Marketing: email@example.com